CVR number 31851939
Industry 72.2000 Research and experimental development on social sciences and humanities

CFKA ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  1.2% 1.2% 1.2% 1.2% 1.2%  
Bankruptcy risk  9.1% 5.4% 4.2% 5.6% 3.2%  
Credit score (0-100)  28 42 47 40 55  
Credit rating  BB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  1,139 1,571 1,710 1,100 1,544  
Gross profit  983 1,462 1,513 935 1,178  
EBITDA  295 644 474 54.9 93.9  
EBIT  295 644 474 54.9 93.9  
Pre-tax profit (PTP)  295.5 685.4 465.1 9.4 200.9  
Net earnings  230.5 534.6 362.8 7.3 156.7  
Pre-tax profit without non-rec. items  295 685 465 9.4 201  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  356 836 1,142 1,052 1,209  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  464 1,022 1,337 1,152 1,799  
Net Debt  -464 -1,022 -1,337 -1,152 -1,799  
 
See the entire balance sheet

Volume 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  1,139 1,571 1,710 1,100 1,544  
Net sales growth  126.9% 37.9% 8.8% -35.7% 40.4%  
Gross profit  983 1,462 1,513 935 1,178  
Gross profit growth  186.4% 48.8% 3.5% -38.2% 26.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  -687.5 -817.8 -1,038.8 -880.2 -1,084.3  
Balance sheet total (assets)  464 1,022 1,337 1,152 1,799  
Balance sheet change%  117.5% 120.5% 30.8% -13.8% 56.1%  
Added value  982.6 1,461.9 1,512.6 935.1 1,178.2  
Added value %  86.3% 93.0% 88.5% 85.0% 76.3%  
Investments  0 0 0 0 0  
Net sales trend  1.0 2.0 3.0 -1.0 1.0  
EBIT trend  5.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  25.9% 41.0% 27.7% 5.0% 6.1%  
EBIT %  25.9% 41.0% 27.7% 5.0% 6.1%  
EBIT to gross profit (%)  30.0% 44.1% 31.3% 5.9% 8.0%  
Net Earnings %  20.2% 34.0% 21.2% 0.7% 10.1%  
Profit before depreciation and extraordinary items %  20.2% 34.0% 21.2% 0.7% 10.1%  
Pre tax profit less extraordinaries %  25.9% 43.6% 27.2% 0.9% 13.0%  
ROA %  87.3% 92.3% 39.4% 0.8% 13.6%  
ROI %  111.0% 115.0% 47.0% 0.9% 17.8%  
ROE %  86.6% 89.7% 36.7% 0.7% 13.9%  

Solidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  76.8% 81.8% 85.4% 91.3% 67.2%  
Relative indebtedness %  9.4% 11.9% 11.4% 9.1% 38.2%  
Relative net indebtedness %  -31.3% -53.2% -66.8% -95.6% -78.3%  
Net int. bear. debt to EBITDA, %  -157.1% -158.7% -282.1% -2,097.6% -1,915.4%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  4.3 5.5 6.9 11.5 3.0  
Current Ratio  4.3 5.5 6.9 11.5 3.0  
Cash and cash equivalent  463.7 1,022.2 1,336.7 1,152.1 1,798.6  

Capital use efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  40.7% 65.1% 78.2% 104.7% 116.5%  
Net working capital  356.3 367.6 454.5 326.5 378.0  
Net working capital %  31.3% 23.4% 26.6% 29.7% 24.5%  

Employee efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0